Pain-sensing neurons exchange signals with immune cells that drive endometriosis, sparking the pain associated with the ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

Doctors and scientists believe migraine is due to "the result of abnormal brain activity affecting nerve signals, chemicals ...

5-hydroxytriptamine is a key mediator in the pathogenesis of migraine and thus 5-HT 1-receptor agonists are the principal drugs for acute migraine therapy. There are three classes of drugs for ...

is thought to explain the common distribution of pain in migraine. Drugs that target the TCC and inhibit neuronal activity in this region are thought to increase the likelihood of being clinically ...

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...

Covering Saudi Arabia’s markets, the report includes: It encompasses a robust vendor analysis tailored to assist clients in enhancing their market positioning. Specifically, the report furnishes a ...

Avoiding triggers, managing stress, and committing to other healthy lifestyle habits are important, but many with episodic migraines also need to take medications—prophylactic drugs that help prevent ...

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.